|
Stadacand Plus tbl 30x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 30x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 50x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 50x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 56x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 56x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 7x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 7x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 90x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 90x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 98x16 mg/12,5 mg (blis.PVC/PVDC/Al)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Stadacand Plus tbl 98x1x16 mg/12,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
16 mg/12,5 mg
|
Tableta |
C09DA06
|
STADA Arzneimittel AG |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 14x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 28x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 30x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 56x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 84x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 90x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmark Plus 80 mg/12,5 mg tbl 98x80 mg/12,5 mg (blis.Al/Al)
80 mg/12,5 mg
|
Tableta |
C09DA07
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Telmisartan HCT EGIS 40 mg/12,5 mg tbl 14x40 mg/12,5 mg (blis.Al/Al)
40 mg/12,5 mg
|
Tableta |
C09DA07
|
Egis Pharmaceuticals PLC |
—
|
|
Telmisartan HCT EGIS 40 mg/12,5 mg tbl 14x40 mg/12,5 mg (blis.Al/PVC/PVDC)
40 mg/12,5 mg
|
Tableta |
C09DA07
|
Egis Pharmaceuticals PLC |
—
|
|
Telmisartan HCT EGIS 40 mg/12,5 mg tbl 28x40 mg/12,5 mg (blis.Al/Al)
40 mg/12,5 mg
|
Tableta |
C09DA07
|
Egis Pharmaceuticals PLC |
—
|
|
Telmisartan HCT EGIS 40 mg/12,5 mg tbl 28x40 mg/12,5 mg (blis.Al/PVC/PVDC)
40 mg/12,5 mg
|
Tableta |
C09DA07
|
Egis Pharmaceuticals PLC |
—
|
|
Telmisartan HCT EGIS 40 mg/12,5 mg tbl 30x40 mg/12,5 mg (blis.Al/Al)
40 mg/12,5 mg
|
Tableta |
C09DA07
|
Egis Pharmaceuticals PLC |
—
|